Healthcare -
Biotechnology - NASDAQ - US
$ 7.9
0.381 %
$ 1.64 B
Market Cap
-12.95
P/E
BCRX - GROSS PROFIT
Gross Profit BCRX - BioCryst Pharmaceuticals, Inc.
327 M
LAST VALUE
47.64%
2 YEAR CAGR
74.52%
5 YEAR CAGR
34.21%
10 YEAR CAGR